Thomas C. Bour serves as the Chief Operating Officer for Barrow Neurological Institute, as well as Chief Executive Officer of NeuroTrials, LLC.  Before joining Barrow, Mr. Bour was a Senior Administrator at the Mayo Clinic Hospital in Phoenix, Arizona. Mr Bour has also previously served as Vice President of Scottsdale Healthcare-Osborn and as a Legislative Assistant for Senator Dave Durenberger (R-Minn).

Katie Cobb is the President of the Barrow Neurological Foundation and has more than 20 years of experience in fundraising, marketing, community relations, media and politics. Prior to joining the Barrow Neurological Foundation, Ms. Cobb served as Senior Vice President for Advancement for Great Hearts Academies, Arizona’s largest Charter Management Organization.  Ms. Cobb is a member of the Board of Directors for NeuroTrials, LLC.

Mr. Giancola’s practice is focused in healthcare compliance, transactions and regulatory matters for healthcare organizations and physicians, including medical staff matters, HIPAA, Stark, ambulatory surgery centers, licensing board investigations, fraud and abuse, peer review, risk management, physician employment contracting, joint ventures, practice formation and separation, and litigation/arbitration. He has extensive trial and mediation experience.  Mr. Giancola leads the legal counsel for NeuroTrials, LLC.

Mr. Gorny is the co-founder and CEO of Unitedweb and Nextiva. He has received numerous awards for his leadership in the technology industry. In 2014 he was recognized as the “Business Leader of the Year” at Arizona Technology Council’s 2014 Governor’s Celebration of Innovation, and in 2017, he was named Top Tech CEO by the Phoenix Business Journal.  Mr. Gorny is a member of the Board of Directors for NeuroTrials, LLC.

Ms. Perez is a transactional attorney whose practice is concentrated in corporate and securities. In addition to providing day-to-day corporate counseling and strategic advice to her clients, Ms. Perez regularly handles a variety of major business transactions, including mergers and acquisitions, venture capital financings, strategic collaborations and commercial transactions.  Ms. Perez is the co-chair of Snell & Wilmer’s Life Science and Medical Technology Industry Group. She has extensive experience in representing biotechnology, life science, medical technology and pharmaceutical companies, including those developing and marketing drugs, diagnostics, medical devices, laboratory tests and genetic tests. As such, Ms. Perez commonly drafts and negotiates commercial agreements involving testing; sponsored research; clinical trials; clinical supply; manufacturing; licensing; joint development; and other collaborative arrangements.

Ms. Perez is a member of the legal team for NeuroTrials, LLC.

Ms. Raess focuses her practice in intellectual property law and technology. She has experience drafting and prosecuting patents and trademarks, as well as counseling on related matters. Simone’s patent practice covers a wide range of technical areas, with experience in biosciences, as well as chemical, mechanical, mining and aerospace patents, among others. Ms. Raess also assists clients in enforcing their intellectual property rights, through licensing negotiations and litigation.  Ms. Raess is a member of the legal team for NeuroTrials, LLC.

Dr. Sanai is an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors. As a practicing neurosurgeon, his specialty clinical practice is devoted entirely to patients with tumors of the brain and spine, including those in high-risk areas. He also has extensive experience using intraoperative mapping techniques to maximize tumor removal while preserving crucial structures controlling motor and language function. Gliomas, meningiomas, metastatic tumors, and complex tumors of the skull base are just some of the tumor types he routinely treats using both operative and radiosurgery techniques.  As the Southwest’s most active dedicated neurosurgical oncologist, with over 2500 brain tumor surgeries performed since 2010, Dr. Sanai has one of the largest experiences in the world.  For this reason and others, Dr. Sanai was recently elected to the American Academy of Neurological Surgeons, the most respected academic organization in neurosurgery.

To date, Dr. Sanai has published over 150 peer-reviewed research manuscripts and delivered over 150 national and international lectures on brain tumor research.  Collectively, Dr. Sanai’s published research has led to over 11,000 total citations and an H-index of 41 – one of the highest for an academic neurosurgeon in the United States, where the median for a Department Chair is 22.  As the Director of the Ivy Brain Tumor Center, Dr. Sanai oversees all translational brain tumor research at the Barrow Neurological Institute, located within the Dignity Health St. Joseph’s Hospital & Medical Center in Phoenix, Arizona.   At the Ivy Center, Dr. Sanai serves as the Principal Investigator of the Laboratory for Stem Cell Neuro-Oncology, which is funded by over a dozen external granting agencies, including the National Institutes of Health (NIH). Dr. Sanai is one of only a handful of neurosurgeons in the United States serving as the principal investigator of multiple NIH R01 grants. 

Dr. Sanai is the principal architect of the Ivy Center’s highly-innovative and world-renown Phase 0 clinical trials program.  Together with a multidisciplinary team of scientists, clinicians, and nurses, Dr. Sanai specializes in identifying new, first-in-class therapeutic agents that match the individual biologies of brain tumor patients.  The Ivy Center’s precision medicine program is the first of its kind in neuro-oncology and reflects Dr. Sanai’s commitment to pushing the envelope for brain tumor patients around the world.